These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18682990)

  • 1. Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
    von Moos R; Strasser F; Gillessen S; Zaugg K
    Support Care Cancer; 2008 Oct; 16(10):1105-15. PubMed ID: 18682990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and pharmacological treatment of bone pain in skeletal metastases.
    Ripamonti C; Fulfaro F
    Q J Nucl Med; 2001 Mar; 45(1):65-77. PubMed ID: 11456377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
    Costa L; Major PP
    Nat Clin Pract Oncol; 2009 Mar; 6(3):163-74. PubMed ID: 19190592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for advanced prostate cancer.
    Yuen KK; Shelley M; Sze WM; Wilt T; Mason MD
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006250. PubMed ID: 17054286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain.
    von Moos R; Costa L; Ripamonti CI; Niepel D; Santini D
    Eur J Cancer; 2017 Jan; 71():80-94. PubMed ID: 27984770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.
    Porta-Sales J; Garzón-Rodríguez C; Llorens-Torromé S; Brunelli C; Pigni A; Caraceni A
    Palliat Med; 2017 Jan; 31(1):5-25. PubMed ID: 27006430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for breast cancer and bone metastases.
    Pecherstorfer M
    Womens Health (Lond); 2009 Mar; 5(2):149-63. PubMed ID: 19245353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of bone-density-conserving agents in the treatment for pain in patients with bone metastases].
    Zhabina AS; Semiglazova TY
    Vopr Onkol; 2015; 61(2):303-10. PubMed ID: 26087615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for malignancy-related bone disease: current status, future developments.
    Body JJ
    Support Care Cancer; 2006 May; 14(5):408-18. PubMed ID: 16450087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for controlling pain from metastatic bone disease.
    Diener KM
    Am J Health Syst Pharm; 1996 Aug; 53(16):1917-27. PubMed ID: 8862204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates in oncology].
    Kurth AA; Heidenreich A; Diel I
    Orthopade; 2007 Feb; 36(2):131-5. PubMed ID: 17252255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic bone disease and tumour-induced hypercalcaemia: treatment options.
    Heatley S
    Int J Palliat Nurs; 2004 Jan; 10(1):41-6. PubMed ID: 14966444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing metastatic bone pain: the role of bisphosphonates.
    Gralow J; Tripathy D
    J Pain Symptom Manage; 2007 Apr; 33(4):462-72. PubMed ID: 17397707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for metastatic bone pain.
    Fine PG; Bellamy C
    J Pain Palliat Care Pharmacother; 2005; 19(3):61-3. PubMed ID: 16219615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
    Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
    J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review.
    Hendriks LE; Hermans BC; van den Beuken-van Everdingen MH; Hochstenbag MM; Dingemans AM
    J Thorac Oncol; 2016 Feb; 11(2):155-73. PubMed ID: 26718881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and treatment of bone complications in prostate cancer.
    Saad F; Clarke N; Colombel M
    Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of bisphosphonates on bone metastasis of hormone-refractory prostate cancer].
    Tanaka T; Kawashima H; Kuratsukuri K; Sugimura K; Nakatani T
    Hinyokika Kiyo; 2006 Jun; 52(6):491-4. PubMed ID: 16848364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone metastases in lung cancer].
    Tsuya A; Fukuoka M
    Clin Calcium; 2008 Apr; 18(4):455-9. PubMed ID: 18379026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.